FOXQ1 and cancer: Indeed, FOXQ1 has been found to be overexpressed in variety of human cancers in digestive organs, such as liver, pancreas, and gastrointestinal tracts, where it could enhance tumorigenicity by inducing epithelial-mesenchymal transition, regulating cell cycle, and promoting cell proliferation [37].